IQVIA earnings date, guidance and results
IQVIA's next results are expected on October 27, 2026. The key thing to watch is whether the backlog review changes backlog quality.
What has IQVIA guided for 2026?
On July 28, 2026, IQVIA raised full-year revenue guidance to $17,275–17,475 million. The midpoint implies 6.5% growth, including 200 basis points from acquisitions and 20 basis points from foreign exchange. A basis point is one-hundredth of a percentage point. Removing those effects leaves about 4.3% growth from the businesses IQVIA already owned.
Management also expects full-year 2026 adjusted EBITDA of $4,000–4,050 million and adjusted diluted earnings per share of $12.80–13.00. Adjusted EBITDA is operating earnings before interest, taxes, depreciation and amortization, after IQVIA removes specified expenses. Adjusted diluted earnings per share divides similarly adjusted profit among shares, including potential dilution.
| Period guided | Low | High | Date given | |
|---|---|---|---|---|
| Revenue | Year to Dec 2026 | 17,275 | 17,475 | Jul 28, 2026 |
| Adjusted EBITDA | Year to Dec 2026 | 4,000 | 4,050 | Jul 28, 2026 |
| Adjusted Diluted Earnings per Share | Year to Dec 2026 | 12.80 | 13.00 | Jul 28, 2026 |
| Mid-point of the revenue growth guidance | Year to Dec 2026 | 6.5% | 6.5% | Jul 28, 2026 |
| Contribution from acquisitions (basis points) | Year to Dec 2026 | 200 | 200 | Jul 28, 2026 |
| Tailwind from foreign exchange (basis points) | Year to Dec 2026 | 20 | 20 | Jul 28, 2026 |
What this means. A basis point is one hundredth of a percentage point, so 200 basis points means 2 percentage points of growth.
Did IQVIA keep its past promises?
Management met its annual promise but not every longer-term ambition. It forecast adjusted earnings per share of US$11.70–US$12.10 for 2025. It delivered US$11.92. The 2023–2025 performance awards paid at 80.9% of target after an adjustment for higher UK corporate tax.
What were IQVIA's last eight quarters of results?
Revenue reached US$4,368 million, against US$4,017 million a year earlier. That followed growth of approximately 8.4% in March 2026, so the improvement was not confined to one quarter.
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4,368 | 4,151 | 4,364 | 4,100 | 4,017 | 3,829 | 3,958 | 3,896 |
| Gross margin | 32.9% | 32.6% | 32.9% | 33.5% | 32.9% | 33.9% | 34.8% | 35.4% |
| Operating income | 506 | 514 | 627 | 553 | 506 | 496 | 626 | 550 |
| Net income | 256 | 274 | 514 | 331 | 266 | 249 | 437 | 285 |
| EPS, diluted | 1.53 | 1.61 | 2.99 | 1.93 | 1.54 | 1.40 | 2.42 | 1.55 |
| = Free cash flow | 360 | 491 | 561 | 772 | 292 | 426 | 721 | 571 |
What this means. Gross margin is not the company's final profit because it leaves out the cost of equipment wearing out over time.
What should IQVIA watchers watch next?
The more revealing disclosure may concern backlog quality. IQVIA was reviewing inactive trials and said a possible adjustment could be around 5%. A signed study can remain in the records while a customer pauses it or little work occurs. Over time, that can make headline backlog larger than the active workload.